Clinical Trial Update: Chiauranib in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma [Phase 2]

View source ↗

Summary

This entry reports a Phase 2 clinical trial of chiauranib for locally advanced or metastatic pancreatic ductal adenocarcinoma, sponsored by Chipscreen Bioscienc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• Chiauranib (Chiauranib)

Snippet

Sponsor: Chipscreen Biosciences, Ltd. | Conditions: Pancreatic Ductal Adenocarcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING